Continuous renal replacement therapy with oXiris® in patients with hematologically malignant septic shock: A retrospective study

doi:10.12998/wjcc.v11.i26.6073

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3643)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

136

WORD

HTML

2166

Figures (1-3)

313

Tables (1-4)

265

Sum=2973

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

119

Download

401

Sum=520

Sep 16, 2023 (publication date) through Jan 7, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 16, 2023; 11(26): 6073-6082
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6073

Table 3 Proportion of negative balance of the two groups on d3 and d4, n (%)

	oXiris^® group (n = 26)	CRRT group (n = 19)	χ²	P value
d3	12/26 (46.2)	5/19 (26.3)	1.838	0.175
d4	15/26 (57.7)	5/19 (26.3)	4.377	0.036^a

^aIndicates statistically significant difference compared with the control group (P < 0.05).

CRRT: Continuous renal replacement therapy; d3 and d4, days 3 and 4.

Citation: Wang J, Wei SR, Ding T, Zhang LP, Weng ZH, Cheng M, Zhou Y, Zhang M, Liu FJ, Yan BB, Wang DF, Sun MW, Cheng WX. Continuous renal replacement therapy with oXiris^® in patients with hematologically malignant septic shock: A retrospective study. World J Clin Cases 2023; 11(26): 6073-6082
URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6073.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6073